PMC:7199903 / 274-643
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T3 | 84-89 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T4 | 147-155 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T5 | 277-290 | Body_part | denotes | glycopeptides | http://purl.org/sig/ont/fma/fma82784 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 6-9 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T3 | 10-12 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T4 | 84-89 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T5 | 94-99 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T6 | 302-303 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T3 | 277-290 | Chemical | denotes | glycopeptides | http://purl.obolibrary.org/obo/CHEBI_24396 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 27-32 | http://purl.obolibrary.org/obo/BFO_0000029 | denotes | sites |
T4 | 44-49 | http://purl.obolibrary.org/obo/BFO_0000029 | denotes | sites |
T5 | 84-89 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
T6 | 94-99 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T7 | 104-110 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infect |
T8 | 364-369 | http://purl.obolibrary.org/obo/BFO_0000029 | denotes | sites |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T39 | 0-5 | NN | denotes | spike |
T40 | 6-9 | VBZ | denotes | has |
T41 | 10-12 | CD | denotes | 22 |
T42 | 13-26 | NN | denotes | glycosylation |
T43 | 27-32 | NNS | denotes | sites |
T44 | 34-37 | WRB | denotes | How |
T45 | 38-43 | DT | denotes | these |
T46 | 44-49 | NNS | denotes | sites |
T47 | 50-53 | VBP | denotes | are |
T48 | 54-66 | VBN | denotes | glycosylated |
T49 | 67-70 | MD | denotes | may |
T50 | 71-77 | VB | denotes | affect |
T51 | 78-83 | WDT | denotes | which |
T52 | 84-89 | NNS | denotes | cells |
T53 | 90-93 | DT | denotes | the |
T54 | 94-99 | NN | denotes | virus |
T55 | 100-103 | MD | denotes | can |
T56 | 104-110 | VB | denotes | infect |
T57 | 111-114 | CC | denotes | and |
T58 | 115-120 | MD | denotes | could |
T59 | 121-127 | VB | denotes | shield |
T60 | 128-132 | DT | denotes | some |
T61 | 133-141 | NNS | denotes | epitopes |
T62 | 142-146 | IN | denotes | from |
T63 | 147-155 | NN | denotes | antibody |
T64 | 156-170 | NN | denotes | neutralization |
T65 | 172-180 | NNP | denotes | Watanabe |
T66 | 181-183 | FW | denotes | et |
T67 | 184-187 | FW | denotes | al. |
T68 | 188-197 | VBN | denotes | expressed |
T69 | 198-201 | CC | denotes | and |
T70 | 202-210 | VBN | denotes | purified |
T71 | 211-222 | JJ | denotes | recombinant |
T72 | 223-235 | VBN | denotes | glycosylated |
T73 | 236-241 | NN | denotes | spike |
T74 | 242-249 | NNS | denotes | trimers |
T75 | 249-250 | -COMMA- | denotes | , |
T76 | 251-262 | VBD | denotes | proteolysed |
T77 | 263-267 | PRP | denotes | them |
T78 | 268-270 | TO | denotes | to |
T79 | 271-276 | VB | denotes | yield |
T80 | 277-290 | NNS | denotes | glycopeptides |
T81 | 291-301 | VBG | denotes | containing |
T82 | 302-303 | DT | denotes | a |
T83 | 304-310 | JJ | denotes | single |
T84 | 311-317 | NN | denotes | glycan |
T85 | 317-318 | -COMMA- | denotes | , |
T86 | 319-322 | CC | denotes | and |
T87 | 323-333 | VBD | denotes | determined |
T88 | 334-337 | DT | denotes | the |
T89 | 338-349 | NN | denotes | composition |
T90 | 350-352 | IN | denotes | of |
T91 | 353-356 | DT | denotes | the |
T92 | 357-363 | NN | denotes | glycan |
T93 | 364-369 | NNS | denotes | sites |
R92 | T89 | T88 | arg1Of | composition,the |
R93 | T89 | T90 | arg1Of | composition,of |
R94 | T93 | T90 | arg2Of | sites,of |
R95 | T93 | T91 | arg1Of | sites,the |
R96 | T93 | T92 | arg1Of | sites,glycan |
R38 | T43 | T40 | arg2Of | sites,has |
R39 | T43 | T41 | arg1Of | sites,22 |
R40 | T43 | T42 | arg1Of | sites,glycosylation |
R41 | T48 | T44 | arg1Of | glycosylated,How |
R42 | T46 | T45 | arg1Of | sites,these |
R43 | T46 | T47 | arg1Of | sites,are |
R44 | T48 | T47 | arg2Of | glycosylated,are |
R45 | T46 | T48 | arg2Of | sites,glycosylated |
R46 | T44 | T49 | arg1Of | How,may |
R47 | T50 | T49 | arg2Of | affect,may |
R48 | T44 | T50 | arg1Of | How,affect |
R49 | T51 | T50 | arg2Of | which,affect |
R50 | T52 | T51 | arg1Of | cells,which |
R51 | T54 | T53 | arg1Of | virus,the |
R52 | T54 | T55 | arg1Of | virus,can |
R53 | T56 | T55 | arg2Of | infect,can |
R54 | T54 | T56 | arg1Of | virus,infect |
R55 | T52 | T56 | arg2Of | cells,infect |
R56 | T50 | T57 | arg1Of | affect,and |
R57 | T59 | T57 | arg2Of | shield,and |
R58 | T44 | T58 | arg1Of | How,could |
R59 | T59 | T58 | arg2Of | shield,could |
R60 | T44 | T59 | arg1Of | How,shield |
R61 | T61 | T59 | arg2Of | epitopes,shield |
R62 | T61 | T60 | arg1Of | epitopes,some |
R63 | T61 | T62 | arg1Of | epitopes,from |
R64 | T64 | T62 | arg2Of | neutralization,from |
R65 | T64 | T63 | arg1Of | neutralization,antibody |
R66 | T74 | T65 | arg1Of | trimers,Watanabe |
R67 | T67 | T66 | arg1Of | al.,et |
R68 | T65 | T67 | arg1Of | Watanabe,al. |
R69 | T67 | T68 | arg2Of | al.,expressed |
R70 | T68 | T69 | arg1Of | expressed,and |
R71 | T70 | T69 | arg2Of | purified,and |
R72 | T67 | T70 | arg2Of | al.,purified |
R73 | T74 | T71 | arg1Of | trimers,recombinant |
R74 | T74 | T72 | arg2Of | trimers,glycosylated |
R75 | T74 | T73 | arg1Of | trimers,spike |
R76 | T86 | T75 | arg1Of | and,"," |
R77 | T74 | T76 | arg1Of | trimers,proteolysed |
R78 | T77 | T76 | arg2Of | them,proteolysed |
R79 | T79 | T76 | arg3Of | yield,proteolysed |
R80 | T79 | T78 | arg1Of | yield,to |
R81 | T77 | T79 | arg1Of | them,yield |
R82 | T80 | T79 | arg2Of | glycopeptides,yield |
R83 | T80 | T81 | arg1Of | glycopeptides,containing |
R84 | T84 | T81 | arg2Of | glycan,containing |
R85 | T84 | T82 | arg1Of | glycan,a |
R86 | T84 | T83 | arg1Of | glycan,single |
R87 | T86 | T85 | arg1Of | and,"," |
R88 | T76 | T86 | arg1Of | proteolysed,and |
R89 | T87 | T86 | arg2Of | determined,and |
R90 | T74 | T87 | arg1Of | trimers,determined |
R91 | T89 | T87 | arg2Of | composition,determined |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T3 | 84-89 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T4 | 147-155 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T5 | 277-290 | Body_part | denotes | glycopeptides | http://purl.org/sig/ont/fma/fma82784 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T3 | 277-290 | Chemical | denotes | glycopeptides | http://purl.obolibrary.org/obo/CHEBI_24396 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 34-171 | Sentence | denotes | How these sites are glycosylated may affect which cells the virus can infect and could shield some epitopes from antibody neutralization. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
18 | 236-241 | Gene | denotes | spike | Gene:43740568 |
21 | 0-5 | Gene | denotes | spike | Gene:43740568 |
22 | 277-290 | Chemical | denotes | glycopeptides | MESH:D006020 |
23 | 311-317 | Chemical | denotes | glycan | MESH:D011134 |
24 | 357-363 | Chemical | denotes | glycan | MESH:D011134 |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 13-26 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 13-26 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 13-26 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 34-171 | Sentence | denotes | How these sites are glycosylated may affect which cells the virus can infect and could shield some epitopes from antibody neutralization. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
18 | 236-241 | Gene | denotes | spike | Gene:43740568 |
21 | 0-5 | Gene | denotes | spike | Gene:43740568 |
22 | 277-290 | Chemical | denotes | glycopeptides | MESH:D006020 |
23 | 311-317 | Chemical | denotes | glycan | MESH:D011134 |
24 | 357-363 | Chemical | denotes | glycan | MESH:D011134 |